How should ureteral stent pain after ureteroscopic kidney stone removal be managed, and how long does the pain typically last?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ureteral Stent Pain After Ureteroscopic Kidney Stone Removal

Direct Answer

For patients experiencing pain after ureteroscopic stone removal with stent placement, prescribe alpha-blockers (such as tamsulosin) combined with anticholinergic medications as first-line therapy, and expect symptoms to resolve within 1-3 weeks after stent removal. 1, 2, 3


Pain Management Strategy

Pharmacologic Management

Alpha-blockers are the cornerstone of stent-related symptom management:

  • Tamsulosin improves stent tolerability by reducing bladder neck and ureteral smooth muscle tone 4, 1
  • Alpha-blockers reduce both flank pain and lower urinary tract symptoms associated with stents 3

Add anticholinergic medications for bladder irritative symptoms:

  • Anticholinergics address frequency, urgency, and suprapubic discomfort caused by bladder trigone irritation from the distal stent curl 3
  • Patients using anticholinergics during stent indwelling experience less pain after stent removal 2

Multimodal analgesia for breakthrough pain:

  • NSAIDs (diclofenac, ibuprofen) are first-line for pain control 5
  • Opioids should be reserved as second-line when NSAIDs are contraindicated 5
  • Anti-inflammatory medications combined with alpha-blockers and anticholinergics provide the most effective symptom control 3

Expected Duration of Symptoms

While Stent is In Place

Approximately 80% of patients experience bothersome symptoms during stent indwelling: 3

  • Flank pain, suprapubic pain, urinary frequency, urgency, dysuria, and hematuria are common 6, 7
  • Symptoms are caused by bladder irritation from the distal curl and reflux of urine through the stent to the renal pelvis 3

After Stent Removal

Post-removal symptoms are extremely common but self-limiting:

  • 64% of patients experience symptoms after stent removal (pain, hematuria, frequency, urgency) 2
  • Among those with symptoms, 60% specifically experience pain/discomfort 2
  • Symptoms typically resolve within 1-3 weeks after removal 2

Risk factors for more severe post-removal pain:

  • Stone basket extraction during the procedure increases post-removal pain 2
  • Patients who experienced significant discomfort while the stent was in place are more likely to have pain after removal 2

Optimal Stent Duration

Minimize stent duration to reduce symptom burden:

  • When stenting is clinically indicated, aim for removal within 14 days when possible 1
  • Longer indwelling stent duration is paradoxically associated with less pain after removal, likely due to tissue adaptation 2
  • Never remove stents prematurely if placed for ureteral injury, stricture, large residual stone burden, solitary kidney, or renal insufficiency 1, 5

When Stenting Can Be Avoided

Routine stenting after uncomplicated ureteroscopy is unnecessary and increases morbidity: 4, 1

Stents can be safely omitted when ALL of the following criteria are met:

  • No suspected ureteral injury during the procedure 1
  • No evidence of ureteral stricture or anatomical impediments 1
  • Normal contralateral kidney function 1
  • No renal functional impairment 1
  • No secondary ureteroscopy procedure planned 1
  • Minimal or no residual stone fragments 1

Stenting is mandatory in these situations:

  • Ureteral trauma or perforation during the procedure 1
  • Significant bleeding requiring tamponade 1
  • Pre-existing ureteral stricture 1
  • Solitary kidney 1
  • Renal insufficiency 1
  • Large residual stone burden requiring drainage 1
  • Active UTI or sepsis at time of procedure 1
  • Pregnancy 1

Common Pitfalls to Avoid

Do not reflexively place stents "just to be safe" after straightforward procedures - this doubles patient morbidity without improving outcomes 1

Do not leave stents in longer than necessary - while longer duration may reduce post-removal pain, the cumulative burden of stent-related symptoms during indwelling outweighs this benefit 1, 2

Do not rely solely on phenazopyridine or oxybutynin alone - these medications showed minimal benefit in reducing stent discomfort compared to placebo in controlled trials 6

Do not dismiss persistent gross hematuria lasting more than 48-72 hours - this warrants diagnostic evaluation for complications such as obstruction or infection 5


Alternative Stent Options

Consider antireflux ureteral stents when available:

  • Antireflux stents significantly reduce flank pain, suprapubic pain, and back soreness during micturition compared to standard stents 8
  • These stents improve quality of life scores and reduce analgesic requirements 8
  • Safety and efficacy are equivalent to standard stents 8

Related Questions

What are the recommended pain management strategies for patients after ureteral stent placement?
What is the likely cause and appropriate management of new flank pain and dysuria after endoscopic kidney stone removal with ureteral stent placement?
Is ureteral stent removal painful?
What is the typical size of a ureteral stent (Fr) used in adult patients?
How do alpha blockers reduce stent-related symptoms?
What is the recommended evaluation and initial management for a 53‑year‑old man with weak urinary stream requiring manual scrotal pressure or sitting to complete voiding, no urgency, frequency, nocturia, hesitancy, dysuria, hematuria, or acute retention, normal prostate‑specific antigen, and a medical history of hypertension (losartan, metoprolol), hypothyroidism (levothyroxine), depression (duloxetine), obesity, hyperlipidemia, and supraventricular tachycardia?
In a patient with psoriasis presenting with epigastric pain radiating to the back, what is the most likely diagnosis and how should it be evaluated and managed?
In a kidney‑transplant recipient with glaucoma, when is systemic acetazolamide safe, what dose is appropriate based on renal clearance, and how should electrolytes and renal function be monitored?
What is the current Food and Drug Administration (FDA) maximum daily dose for Adderall (mixed‑amphetamine salts) and Adderall XR (extended‑release mixed‑amphetamine)?
What is the proper flushing protocol for maintaining patency of an implanted venous access port (Port‑a‑Cath)?
What is the appropriate management for an elderly skilled‑nursing facility resident with a total serum calcium of 7.7 mg/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.